Positive indication means upadacitinib will be available to those with previously treated severe active RA*
SMC approval is based on data from pivotal Ph... Read More...
The Pharmacists' Defence Association (PDA) has launched a new campaign that is calling on all pharmacists to have the COVID-19 vaccine and to help encourage the... Read More...
Two funds, worth £1 million each, will open this week to support grassroots, community and residential organisations to improve drugs services.
A £1 million ... Read More...
The General Pharmaceutical Council (GPhC) has announced that candidates for the upcoming registration assessment, who are currently in countries with more than ... Read More...
Dr Gray’s Hospital in Elgin will provide enhanced diagnostic capacity for patients suffering from urological cancers in the North of Scotland from later this mo... Read More...
Photo courtesy of Michael Gillen, Falkirk Herald.
Forth Valley patients have played a vital role in research which shows that a drug normally used to treat ar... Read More...
There’s a lot of pressure on you right now: vaccinations, increased prescription volume, social distancing rules and increasing numbers of unwell people.
To ... Read More...
Scottish Medicines Consortium (SMC) has accepted PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer.
Leupro... Read More...
Recent studies have shown that more than 650,000 people with cancer in the UK (22%) have experienced disruption to their cancer treatment or care because of COV... Read More...
The MHRA has launched a public consultation on the reclassification of two progestogen-only contraceptive pills containing desogestrel. This is the first time... Read More...
Healthcare Professional ONLY
This website is intended for Healthcare professionals only
Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors
